Global Perampanel Tablets 麻豆原创 Growth 2024-2030

Publication ID:

LPI11241886

Publication Date:

November 6, 2024

Pages:

100

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Perampanel Tablets is an anti-epileptic drug, mainly used as an adjunctive treatment for partial epileptic seizures (including secondary generalized epilepsy) and primary generalized tonic-clonic seizures in patients aged 12 years and above. Perampanel is a non-competitive AMPA (伪-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor antagonist, and its mechanism of action is to inhibit the action of the excitatory neurotransmitter glutamate by selectively blocking AMPA receptors, thereby reducing the frequency of epileptic seizures.
The global Perampanel Tablets market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淧erampanel Tablets Industry Forecast鈥� looks at past sales and reviews total world Perampanel Tablets sales in 2023, providing a comprehensive analysis by region and market sector of projected Perampanel Tablets sales for 2024 through 2030. With Perampanel Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Perampanel Tablets industry.
This Insight Report provides a comprehensive analysis of the global Perampanel Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Perampanel Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Perampanel Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Perampanel Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Perampanel Tablets.
United States market for Perampanel Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Perampanel Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Perampanel Tablets is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Perampanel Tablets players cover Eisai Europe Limited, Novartis Pharmaceuticals, Pfizer Inc., Merck, China Resources Sanjiu Medical & Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Perampanel Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
2mg
4mg
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Eisai Europe Limited
Novartis Pharmaceuticals
Pfizer Inc.
Merck
China Resources Sanjiu Medical & Pharmaceutical
Dr. Reddy's Laboratories
Sun Pharmaceutical Industries
Key Questions Addressed in this Report
What is the 10-year outlook for the global Perampanel Tablets market?
What factors are driving Perampanel Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Perampanel Tablets market opportunities vary by end market size?
How does Perampanel Tablets break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Perampanel Tablets Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Perampanel Tablets by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Perampanel Tablets by Country/Region, 2019, 2023 & 2030
2.2 Perampanel Tablets Segment by Type
2.2.1 2mg
2.2.2 4mg
2.3 Perampanel Tablets Sales by Type
2.3.1 Global Perampanel Tablets Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Perampanel Tablets Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Perampanel Tablets Sale Price by Type (2019-2024)
2.4 Perampanel Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Perampanel Tablets Sales by Application
2.5.1 Global Perampanel Tablets Sale 麻豆原创 Share by Application (2019-2024)
2.5.2 Global Perampanel Tablets Revenue and 麻豆原创 Share by Application (2019-2024)
2.5.3 Global Perampanel Tablets Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Perampanel Tablets Breakdown Data by Company
3.1.1 Global Perampanel Tablets Annual Sales by Company (2019-2024)
3.1.2 Global Perampanel Tablets Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Perampanel Tablets Annual Revenue by Company (2019-2024)
3.2.1 Global Perampanel Tablets Revenue by Company (2019-2024)
3.2.2 Global Perampanel Tablets Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Perampanel Tablets Sale Price by Company
3.4 Key Manufacturers Perampanel Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Perampanel Tablets Product Location Distribution
3.4.2 Players Perampanel Tablets Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Perampanel Tablets by Geographic Region
4.1 World Historic Perampanel Tablets 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Perampanel Tablets Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Perampanel Tablets Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Perampanel Tablets 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Perampanel Tablets Annual Sales by Country/Region (2019-2024)
4.2.2 Global Perampanel Tablets Annual Revenue by Country/Region (2019-2024)
4.3 Americas Perampanel Tablets Sales Growth
4.4 APAC Perampanel Tablets Sales Growth
4.5 Europe Perampanel Tablets Sales Growth
4.6 Middle East & Africa Perampanel Tablets Sales Growth
5 Americas
5.1 Americas Perampanel Tablets Sales by Country
5.1.1 Americas Perampanel Tablets Sales by Country (2019-2024)
5.1.2 Americas Perampanel Tablets Revenue by Country (2019-2024)
5.2 Americas Perampanel Tablets Sales by Type (2019-2024)
5.3 Americas Perampanel Tablets Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Perampanel Tablets Sales by Region
6.1.1 APAC Perampanel Tablets Sales by Region (2019-2024)
6.1.2 APAC Perampanel Tablets Revenue by Region (2019-2024)
6.2 APAC Perampanel Tablets Sales by Type (2019-2024)
6.3 APAC Perampanel Tablets Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Perampanel Tablets by Country
7.1.1 Europe Perampanel Tablets Sales by Country (2019-2024)
7.1.2 Europe Perampanel Tablets Revenue by Country (2019-2024)
7.2 Europe Perampanel Tablets Sales by Type (2019-2024)
7.3 Europe Perampanel Tablets Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Perampanel Tablets by Country
8.1.1 Middle East & Africa Perampanel Tablets Sales by Country (2019-2024)
8.1.2 Middle East & Africa Perampanel Tablets Revenue by Country (2019-2024)
8.2 Middle East & Africa Perampanel Tablets Sales by Type (2019-2024)
8.3 Middle East & Africa Perampanel Tablets Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Perampanel Tablets
10.3 Manufacturing Process Analysis of Perampanel Tablets
10.4 Industry Chain Structure of Perampanel Tablets
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Perampanel Tablets Distributors
11.3 Perampanel Tablets Customer
12 World Forecast Review for Perampanel Tablets by Geographic Region
12.1 Global Perampanel Tablets 麻豆原创 Size Forecast by Region
12.1.1 Global Perampanel Tablets Forecast by Region (2025-2030)
12.1.2 Global Perampanel Tablets Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Perampanel Tablets Forecast by Type (2025-2030)
12.7 Global Perampanel Tablets Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Eisai Europe Limited
13.1.1 Eisai Europe Limited Company Information
13.1.2 Eisai Europe Limited Perampanel Tablets Product Portfolios and Specifications
13.1.3 Eisai Europe Limited Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Eisai Europe Limited Main Business Overview
13.1.5 Eisai Europe Limited Latest Developments
13.2 Novartis Pharmaceuticals
13.2.1 Novartis Pharmaceuticals Company Information
13.2.2 Novartis Pharmaceuticals Perampanel Tablets Product Portfolios and Specifications
13.2.3 Novartis Pharmaceuticals Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Novartis Pharmaceuticals Main Business Overview
13.2.5 Novartis Pharmaceuticals Latest Developments
13.3 Pfizer Inc.
13.3.1 Pfizer Inc. Company Information
13.3.2 Pfizer Inc. Perampanel Tablets Product Portfolios and Specifications
13.3.3 Pfizer Inc. Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pfizer Inc. Main Business Overview
13.3.5 Pfizer Inc. Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Perampanel Tablets Product Portfolios and Specifications
13.4.3 Merck Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 China Resources Sanjiu Medical & Pharmaceutical
13.5.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
13.5.2 China Resources Sanjiu Medical & Pharmaceutical Perampanel Tablets Product Portfolios and Specifications
13.5.3 China Resources Sanjiu Medical & Pharmaceutical Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 China Resources Sanjiu Medical & Pharmaceutical Main Business Overview
13.5.5 China Resources Sanjiu Medical & Pharmaceutical Latest Developments
13.6 Dr. Reddy's Laboratories
13.6.1 Dr. Reddy's Laboratories Company Information
13.6.2 Dr. Reddy's Laboratories Perampanel Tablets Product Portfolios and Specifications
13.6.3 Dr. Reddy's Laboratories Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dr. Reddy's Laboratories Main Business Overview
13.6.5 Dr. Reddy's Laboratories Latest Developments
13.7 Sun Pharmaceutical Industries
13.7.1 Sun Pharmaceutical Industries Company Information
13.7.2 Sun Pharmaceutical Industries Perampanel Tablets Product Portfolios and Specifications
13.7.3 Sun Pharmaceutical Industries Perampanel Tablets Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Sun Pharmaceutical Industries Main Business Overview
13.7.5 Sun Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.